// Milonic DHTML Menu version 3.3.11

// The following line is critical for menu operation, and must appear only once.
menunum=0;menus=new Array();_d=document;function addmenu(){menunum++;menus[menunum]=menu;}function dumpmenus(){mt="<script language=javascript>";for(a=1;a<menus.length;a++){mt+=" menu"+a+"=menus["+a+"];"}mt+="<\/script>";_d.write(mt)}
//Please leave the above line intact

////////////////////////////////////
// Editable properties START here //
////////////////////////////////////


effect = "Fade(duration=0.3);Alpha(style=0,opacity=95);Shadow(color='#999999', Direction=135, Strength=5)" // Special effect string for IE5.5 or above please visit http://www.milonic.co.uk/menu/filters_sample.php for more filters

timegap=500				// The time delay for menus to remain visible
followspeed=10			// Follow Scrolling speed
followrate=10			// Follow Scrolling Rate
suboffset_top=5;		// Sub menu offset Top position 
suboffset_left=-5;		// Sub menu offset Left position

style1=[				// style1 is an array of properties. You can have as many property arrays as you need. This means that menus can have their own style.
"74F7F7",				// Mouse Off Font Color
"000066",				// Mouse Off Background Color
"000066",				// Mouse On Font Color
"74F7F7",				// Mouse On Background Color
"fffff0",				// Menu Border Color 
11,						// Font Size in pixels
"normal",				// Font Style (italic or normal)
"bold",					// Font Weight (bold or normal)
"Verdana, Arial",		// Font Name
4,						// Menu Item Padding
,						// Sub Menu Image (Leave this blank if not needed)
,						// 3D Border & Separator bar
"66ffff",				// 3D High Color
"000099",				// 3D Low Color
"ffffff",				// Current Page Item Font Color (leave this blank to disable)
"lightslategray",		// Current Page Item Background Color (leave blank to disable)
,						// Top Bar image (Leave this blank to disable)
"ffffff",				// Menu Header Font Color (Leave blank if headers are not needed)
"000099",				// Menu Header Background Color (Leave blank if headers not needed)
]

addmenu(menu=[		// This is the array that contains your menu properties and details
"mainmenu",			// Menu Name - This is needed in order for the menu to be called
5,					// Menu Top - The Top position of the menu in pixels
0,					// Menu Left - The Left position of the menu in pixels
,					// Menu Width - Menus width in pixels
,					// Menu Border Width 
"center",		// Screen Position - here you can use "center;left;right;middle;top;bottom" or a combination of "center:middle"
style1,				// Properties Array - this is set higher up, as above
1,					// Always Visible - allows the menu item to be visible at all time (1=on/0=off)
"center",			// Alignment - sets the menu elements text alignment, values valid here are: left, right or center
effect,				// Filter - Text variable for setting transitional effects on menu activation - see above for more info
1,					// Follow Scrolling - Tells the menu item to follow the user down the screen (visible at all times) (1=on/0=off)
1, 					// Horizontal Menu - Tells the menu to become horizontal instead of top to bottom style (1=on/0=off)
1,					// Keep Alive - Keeps the menu visible until the user moves over another menu or clicks elsewhere on the page (1=on/0=off)
,					// Position of TOP sub image left:center:right
,					// ..Now Obsolete..
,					// Right To Left - Used in Hebrew for example. (1=on/0=off)
,					// Open the Menus OnClick - leave blank for OnMouseover (1=on/0=off)
,					// ID of the div you want to hide on MouseOver (useful for hiding form elements)
,					// Reserved for future use
,					// Reserved for future use
,					// Reserved for future use
// "Description Text", "URL", "Alternate URL", "Status", "Separator Bar"
,"Home","index.php",,"",1
,"News","show-menu=news",,"",1
,"Articles","show-menu=articles",,"",1
,"Understanding...","show-menu=understanding",,"",1
,"Events","show-menu=congress",,"",1
,"Toolbox","show-menu=tools",,"",1
,"Free-4-all","show-menu=free",,"",1
,"Links","links.htm",,"",1
,"Classified.ads","show-menu=ads",,"",1
,"Medline","medline.htm",,"",1
,"Editorial.Board ","ed_board.htm",,"",1
//,"Satisfaction.Survey ","survey/satisfaction_survey.htm",,"",1
,"About","show-menu=legal",,"",1
,"Contact","mailto:editor@psy-world.com",,"",1	
])
	
	addmenu(menu=["news",
	,,220,0,"",style1,,"left",effect,,,,,,,,,,,,
	,"Latest news","latest_news.php",,,0
	,"News archives","show-menu=archives",,,0
//	,"News from meetings in 2005","show-menu=2005_meetings",,,0
//	,"News from meetings in 2006","show-menu=2006_meetings",,,0
//	,"News from meetings in 2008","show-menu=2008_meetings",,,0
	,"News from the Agencies","agencies.htm",,,0
	,"Selected reviews","show-menu=select_reviews",,,0
	,"Book reviews","show-menu=bookreviews",,,0
	,"Featured journals","show-menu=featured_journals",,,0
	,"Controversy","show-menu=controversy",,,0
	])
	
	addmenu(menu=["2005_meetings",
	,,160,0,"",style1,,"left",effect,,,,,,,,,,,,
	,"News from APA 2005","apanews.htm",,,0
	,"News from BAP 2005","bapnews.htm",,,0
	,"News from ECNP 2005","ecnp2005news.htm",,,0
	,"News from IFMAD 2005","ifmad2005news.htm",,,0		
	])
		
	addmenu(menu=["2006_meetings",
	,,160,0,"",style1,,"left",effect,,,,,,,,,,,,
	,"News from ISAD 2006","isad2006news.htm",,,0
	,"News from CINP 2006","cinpnews2006.htm",,,0
	,"News from ECNP 2006","ecnp2006news.htm",,,0	
	])
		
	addmenu(menu=["2008_meetings",
	,,160,0,"",style1,,"left",effect,,,,,,,,,,,,
	,"News from ECNP 2008","ecnp2008news.htm",,,0	
	])
	
	addmenu(menu=["archives",
	,,160,0,"",style1,,"left",effect,,,,,,,,,,,,
	,"News archives 2011","news_archives_2011.php",,,0
	,"News archives 2010","news_archives_2010.php",,,0
	,"News archives 2009","news_archives_2009.php",,,0
	,"News archives 2008","news_archives_2008.php",,,0
	,"News archives 2007","news_archives_2007.php",,,0
	,"News archives 2006","news_archives_2006.php",,,0
	,"News archives 2005","news_archives_2005.php",,,0
	,"News archives 2004","news_archives_2004.php",,,0
	])
	
	addmenu(menu=["tools",
	,,250,0,"",style1,,"left",effect,,,,,,,,,,,,
	,"On-line screening tools","show-menu=on-line_screening",,,0	
	,"Rating scales","show-menu=scales",,,0
	,"Diagnostic tools & criteria","show-menu=diagnostic",,,0
	,"Treatment guidelines","show-menu=guidelines","guidelines.htm",,0
	,"Psychiatry & Neurobiology Slide Library","show-menu=slides",,,0
	,"Psychiatry & Neurobiology Video Library","show-menu=videos",,,0
	,"Tips on publishing & presenting","show-menu=tips",,,0
	])
	
	addmenu(menu=["free",
	,,200,0,"",style1,,"left",effect,,,,,,,,,,,,
	,"Free books","show-menu=free_books",,,0
	,"Free journals","free_journals.htm",,,0
	,"Free psychiatry newsletters","free_newsletters.htm",,,0
	,"Free psychiatry podcasts","free_podcasts.htm",,,0
	,"Free psychiatry blogs","psy-blogs.htm",,,0
	])
	
	addmenu(menu=["free_books",
	,,150,0,"",style1,,"left",effect,,,,,,,,,,,,
	,"Medical Students & General public","free_books_pub.htm",,,0
	,"Health professionals","free_books_med.htm",,,0
	])

	addmenu(menu=["articles",
	,,280,0,"",style1,,"left",effect,,,,,,,,,,,,
	,"Articles by Stephen Stahl<BR>in collaboration with CNS Spectrums","show-menu=stahl_articles",,,0
	,"Problems associated with long-term treatment with SSRIs<BR>by Chantal Moret and Mike Isaac","ssri_problems.htm",,,0
	,"Teen Depression<BR>by Keith Allen","teen_depression.htm",,,0
	,"Depression in the elderly<BR>by Jean-Pierre Olié","elderly.htm",,,0
	,"Choosing the right antidepressant<BR>by David Baldwin","choosing.htm",,,0
	,"Treating pain in depression<BR>by Mike Briley","pain.htm",,,0
	,"Articles from Stephen Stahl<BR> in collaboration with the Neuroscience Education Institute (series discontinued)","show-menu=stahl",,,0
	])

	addmenu(menu=["select_reviews",
	,,350,0,"",style1,,"left",effect,,,,,,,,,,,,
	,"*NEW* 85. Internet pathways in suicidality: a review of the evidence.","select_rev85.htm",,,0
	,"84. Potential Antidepressant Role of Neurotransmitter CART.","select_rev84.htm",,,0
	,"83. Post-stroke depression and apathy","select_rev83.htm",,,0
	,"82. Antidepressants in pregnancy: a systematic review","select_rev82.htm",,,0
	,"81. Beyond the serotonin hypothesis: Mitochondria, inflammation and neurodegeneration in major depression and affective spectrum disorders","select_rev81.htm",,,0
	,"Previous Reviews 71-80","show-menu=select_reviews(8)",,,0
	,"Previous Reviews 61-70","show-menu=select_reviews(7)",,,0
	,"Previous Reviews 51-60","show-menu=select_reviews(6)",,,0
	,"Previous Reviews 41-50","show-menu=select_reviews(5)",,,0
	,"Previous Reviews 31-40","show-menu=select_reviews(4)",,,0
	,"Previous Reviews 21-30","show-menu=select_reviews(3)",,,0
	,"Previous Reviews 11-20","show-menu=select_reviews(2)",,,0
	,"Previous Reviews 1-10","show-menu=select_reviews(1)",,,0
	])

	addmenu(menu=["select_reviews(8)",
	,,350,0,"",style1,,"left",effect,,,,,,,,,,,,
	,"80. Personalized Medicine for Depression: Can We Match Patients With Treatments?","select_rev80.htm",,,0
	,"79. A generalist's guide to treating patients with depression with an emphasis on using side effects to tailor antidepressant therapy.","select_rev79.htm",,,0
	,"78. Depression or menopause? Presentation and management of major depressive disorder in perimenopausal and postmenopausal women.","select_rev78.htm",,,0
	,"77. Emotional enhancement of memory: how norepinephrine enables synaptic plasticity.","select_rev77.htm",,,0
	,"76. Relevance of Norepinephrine-Dopamine Interactions in the Treatment of Major Depressive Disorder.","select_rev76.htm",,,0
	,"75. Reward and Punishment Processing in Depression.","select_rev75.htm",,,0
	,"74. 2010 Guide to Psychiatric Drug Interactions.","select_rev74.htm",,,0
	,"73. Antidepressants are a rational complementary therapy for the treatment of Alzheimer's disease.","select_rev73.htm",,,0
	,"72. Regulation of adult neurogenesis by stress, sleep disruption, exercise and inflammation: Implications for depression and antidepressant action.","select_rev72.htm",,,0
	,"71. Role of brain-derived neurotrophic factor in the aetiology of depression.","select_rev71.htm",,,0
		])

	addmenu(menu=["select_reviews(7)",
	,,350,0,"",style1,,"left",effect,,,,,,,,,,,,
	,"70. Depression and perimenopause: a review.","select_rev70.htm",,,0
	,"69. Critical appraisal and update on the clinical utility of agomelatine.","select_rev69.htm",,,0
	,"68. SSRIs, bone mineral density, and risk of fractures.","select_rev68.htm",,,0
	,"67. Atypical antipsychotic augmentation in major depressive disorder: A meta-analysis of placebo-controlled randomized trials.","select_rev67.htm",,,0
	,"66. Structural brain abnormalities in major depressive disorder: A selective review of recent MRI studies.","select_rev66.htm",,,0
	,"65. Two different putative genetic animal models of childhood depression","select_rev65.htm",,,0
	,"63-64. 5-HT(1A) receptor function in major depressive disorder AND The Serotonin-1A Receptor in Anxiety Disorders","select_rev63_64.htm",,,0
	,"62. Lithium and Neuropsychiatric Therapeutics","select_rev62.htm",,,0
	,"61. Is schizoaffective disorder a distinct categorical diagnosis?","select_rev61.htm",,,0
		])
			
	addmenu(menu=["select_reviews(6)",
	,,350,0,"",style1,,"left",effect,,,,,,,,,,,,
	,"60. Adult ADHD and comorbid depression: A consensus-derived diagnostic algorithm for ADHD.","select_rev60.htm",,,0
	,"59. Biological substrates of reward and aversion: a nucleus accumbens activity hypothesis.","select_rev59.htm",,,0
	,"58. Dual- and Triple-Acting Agents for Treating Depression: Novel Concepts, New Drugs.","select_rev58.htm",,,0
	,"57. Effectiveness of treatment with antidepressants in fibromyalgia syndrome.","select_rev57.htm",,,0
	,"56. Obesity and vulnerability of the CNS.","select_rev56.htm",,,0
	,"55. Dynamics of the dopaminergic system as a key component to the understanding of depression.","select_rev55.htm",,,0
	,"54. Psychopharmacotherapy of posttraumatic stress disorder","select_rev54.htm",,,0
	,"53. Vasopressin antagonists as anxiolytics and antidepressants: recent developments","select_rev53.htm",,,0
	,"52. Combination treatment with benzodiazepines and SSRIs for comorbid anxiety and depression","select_rev52.htm",,,0
	,"51. Psychostimulants for depression","select_rev51.htm",,,0
		])

	addmenu(menu=["select_reviews(5)",
	,,350,0,"",style1,,"left",effect,,,,,,,,,,,,
	,"50. 'It's not over when it's over': persistent neurobiological abnormalities in recovered depressed patients","select_rev50.htm",,,0
	,"49. A Systematic Review of Chronic Fatigue Syndrome: Don't Assume It\'s Depression","select_rev49.htm",,,0
	,"48. An evidence-based review updating the various treatment and management approaches to serotonin reuptake inhibitor-associated sexual dysfunction","select_rev48.htm",,,0
	,"47. Antidepressants in short-term treatment of binge eating disorder: Systematic review and meta-analysis","select_rev47.htm",,,0
	,"46. Antiglucocorticoid treatments for mood disorders","select_rev46.htm",,,0
	,"45. Benefits and risks of using antidepressants in children and adolescents","select_rev45.htm",,,0
	,"44. A possible role for the endocannabinoid system in the neurobiology of depression","select_rev44.htm",,,0
	,"43. Adult neural stem cells: The promise of the future","select_rev43.htm",,,0
	,"42. Limitations of current medical treatments for depression: Disturbed circadian rhythms as a possible therapeutic target.","select_rev42.htm",,,0
	,"41. Triple uptake inhibitors: therapeutic potential in depression and beyond","select_rev41.htm",,,0
		])
		
	addmenu(menu=["select_reviews(4)",
	,,250,0,"",style1,,"left",effect,,,,,,,,,,,,
	,"40. A Meta-Analytic Review of Double-Blind, Placebo-Controlled Trials of Antidepressant Efficacy of Omega-3 Fatty Acids","select_rev40.htm",,,0
	,"39. The other face of depression, reduced positive affect: the role of catecholamines in causation and cure","select_rev39.htm",,,0
	,"38. Brain mechanisms underlying the placebo effect in neurological disorders","select_rev38.htm",,,0	
	,"37. The selegiline transdermal system in major depressive disorder","select_rev37.htm",,,0
	,"36. Tricyclic antidepressant pharmacology and therapeutic drug interactions updated","select_rev36.htm",,,0
	,"35. Neural stem cell therapy for neuropsychiatric disorders","select_rev35.htm",,,0
	,"34. Serotonin reuptake inhibitors in pregnancy and the risk of major malformations","select_rev34.htm",,,0
	,"33. European Study of the Epidemiology of Mental Disorders","select_rev33.htm",,,0
	,"32. Resurrecting melancholia.","select_rev32.htm",,,0
	,"31. Cost-of-illness studies of depression.","select_rev31.htm",,,0
	])
			
	addmenu(menu=["select_reviews(3)",
	,,250,0,"",style1,,"left",effect,,,,,,,,,,,,
	,"30. Glycogen synthase kinase-3 (GSK-3) as a target for new treatments for mood disorders. ","select_rev30.htm",,,0
	,"29. Noradrenergic Pain Modulation ","select_rev29.htm",,,0
	,"28. SSRI-Associated Sexual Dysfunction","select_rev28.htm",,,0
	,"27. The immune system and happiness","select_rev27.htm",,,0
	,"26. Bipolar disorders: treatment options and patient satisfaction","select_rev26.htm",,,0
	,"25. The Genetics of Depression ","select_rev25.htm",,,0
	,"24. Omega-3 Fatty Acids and Mood Disorders ","select_rev24.htm",,,0
	,"23. A Review of Serotonin Toxicity Data: Implications for the Mechanisms of Antidepressant Drug Action","select_rev23.htm",,,0
	,"22. Darwinian models of depression: A review of evolutionary accounts of mood and mood disorders.","select_rev22.htm",,,0
	,"21. Serotonin-Norepinephrine Reuptake Inhibitors in the Treatment of Obsessive-Compulsive Disorder: A Critical Review.","select_rev21.htm",,,0
	])
	
	addmenu(menu=["select_reviews(2)",
	,,250,0,"",style1,,"left",effect,,,,,,,,,,,,
	,"11. Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment.","select_rev11.htm",,,0
	,"12. Rapid cycling bipolar disorder:biology and pathogenesis","select_rev12.htm",,,0
	,"13. SNRIs in comparison with other antidepressants","select_rev13.htm",,,0
	,"14. Pharmacological treatment for psychotic depression","select_rev14.htm",,,0
	,"15. Selective estrogen receptor modulators (SERMs) for the brain.","select_rev15.htm",,,0
	,"16. Antidepressant treatments and human aggression","select_rev16.htm",,,0
	,"17. Placebo response in clinical trials of depression and its implications for research on chronic neuropathic pain","select_rev17.htm",,,0
	,"18. The role of CREB in depression and antidepressant treatment","select_rev18.htm",,,0
	,"19. Anticonvulsants in the treatment of bipolar mania ","select_rev19.htm",,,0
	,"20. The mesolimbic dopamine reward circuit in depression","select_rev20.htm",,,0
	])
	
	addmenu(menu=["select_reviews(1)",
	,,250,0,"",style1,,"left",effect,,,,,,,,,,,,
	,"10. Do substance P and the NK1 receptor have a role in depression and anxiety?","select_rev10.htm",,,0
	,"9. Review of magnetic resonance imaging and spectroscopy studies in children with bipolar disorder","select_rev08_09.htm#review9",,,0		
	,"8. Neuroimaging of bipolar disorder: emphasis on novel MRI techniques","select_rev08_09.htm#review8",,,0		
	,"7. Is dose escalation of antidepressants a rational strategy after a medium-dose treatment has failed?","select_rev07.htm",,,0		
	,"6. Social Functioning : Should it Become an Endpoint in Trials of Antidepressants?","select_rev06.htm",,,0		
	,"5. Overview of diagnosis and treatment of anxiety disorders","select_rev05.htm",,,0		
	,"4. Antidepressants in the treatment of irritable bowel syndrome and visceral pain syndromes","select_rev04.htm",,,0		
	,"3. Bipolar depression: phenomenological overview and clinical characteristics","select_rev03.htm",,,0		
	,"2. The effectiveness of divalproate in mania and bipolar depression","select_rev02.htm",,,0
	,"1. Afferent pain pathways: a neuroanatomical review","select_rev01.htm",,,0
	])

	addmenu(menu=["bookreviews",
	,,400,0,"",style1,,"left",effect,,,,,,,,,,,,
	,"Best Practices for Medical Educators by Stephen Stahl and Richard L. Davis","bookreview07.htm",,,0
	,"Medicines for Mental Health: The Ultimate Guide to Psychiatric Medication by Kevin Thompson","bookreview06.htm",,,0
	,"Guide to Receptors and Channels by Alexander et al","bookreview05.htm",,,0
	,"Writing Scientific Papers by Tim North","bookreview04.htm",,,0
	,"Illustrated insights - Excessive Sleepiness by Stephen Stahl","bookreview03.htm",,,0
	,"Free Medical Information: Doctor = Publisher by Bernd Sebastian Kamps","bookreview02.htm",,,0
	,"Fast Facts - Depression by Baldwin & Hirschfeld","bookreview01.htm",,,0
	])
	
	addmenu(menu=["featured_journals",
	,,320,0,"",style1,,"left",effect,,,,,,,,,,,,
	,"Journal of Visualized Experiments","show-menu=jove",,,0
	,"Neuropsychiatric Disease and Treatment","show-menu=ndt",,,0
	,"CNS Spectrums","show-menu=cns_spectrums",,,0
	,"International Journal of Psychiatry in Clinical Practice","show-menu=ijpcp",,,0
	])

	addmenu(menu=["tips",
	,,180,0,"",style1,,"left",effect,,,,,,,,,,,,
	,"Writing papers","show-menu=writing",,,0
	,"Writing tips by Tim North","show-menu=North",,,0
	,"Making presentations","show-menu=presentations",,,0
	])
		
	addmenu(menu=["writing",
	,,200,0,"",style1,,"left",effect,,,,,,,,,,,,
	,"Reflections on Post Publication Peer Review - a new publication model","post_pub_peer_rev.htm",,,0
	,"Replying to referees\' comments","replying_to_referees.htm",,,0
	,"Checklist for writing a scientific paper","scientific_paper_checklist.htm",,,0
	,"Open Access - what will it change?","open_access.htm",,,0
	,"An introduction to writing scientific papers","writing_tips(1).htm",,,0
	])
		
	addmenu(menu=["North",
	,,200,0,"",style1,,"left",effect,,,,,,,,,,,,
	,"Apostrophes: a gentle introduction","apostrophes.htm",,,0
	,"\"Less\" or \"fewer\": Is there still a difference?","less_or_fewer.htm",,,0
	,"Do you \"take\" or \"make\" a decision?","take_make_decisions.htm",,,0
	,"Active and passive voices made simple","active_passive.htm",,,0
	,"Affect or effect: its harder than you think!","affect_effect.htm",,,0
	,"Are full stops placed inside or outside quotation marks?","quotation_marks.htm",,,0
	,"Ten tips for better e-mail","e-mails.htm",,,0
	,"Hyphens made easy","hyphens.htm",,,0
	,"\"Which\" or \"that\" - Choosing between them made easy","which_that.htm",,,0
	,"Fonts - choosing wisely","fonts.htm",,,0
	])
		
	addmenu(menu=["presentations",
	,,200,0,"",style1,,"left",effect,,,,,,,,,,,,
	,"Basic rules for effective Powerpoint presentations","making_slides(4).htm",,,0
	,"Making effective Powerpoint presentations","making_slides(1).htm",,,0
	,"A-Z of making oral presentations","presentations(1).htm",,,0
	])
		
	addmenu(menu=["videos",
	,,100,0,"",style1,,"left",effect,,,,,,,,,,,,
	,"Latest videos","videos.htm",,,0
	])
		
	addmenu(menu=["slides",
	,,250,0,"",style1,,"left",effect,,,,,,,,,,,,
	,"Psychiatry slides","slides.htm",,,0
	,"Neurobiology and Neurology slides","slides(2).htm",,,0
	])
		
	addmenu(menu=["on-line_screening",
	,,210,0,"",style1,,"left",effect,,,,,,,,,,,,
	,"Depression screening","depression_test.htm",,,0
	,"Online Hamilton Depression Rating Scale","online_hamd.htm",,,0
	])
		
	addmenu(menu=["guidelines",
	,,150,0,"",style1,,"left",effect,,,,,,,,,,,,
	,"Depression","guidelines(1).htm",,,0
 	,"Anxiety","show-menu=anxiety_guidelines",,,0
 	,"Dementia","guidelines(3).htm",,,0
 	,"Substance abuse","guidelines(4).htm",,,0
 	,"Eating disorders","guidelines(5).htm",,,0
	])

	addmenu(menu=["anxiety_guidelines",
	,,210,0,"",style1,,"left",effect,,,,,,,,,,,,
	,"Anxiety in general","guidelines(2).htm",,,0
	,"Obsessive compusive disorder","guidelines(2).htm#ocd",,,0
 	,"Panic disorder","guidelines(2).htm#panic",,,0
 	,"PTSD","guidelines(2).htm#ptsd",,,0
	])

	addmenu(menu=["ads",
	,,100,0,"",style1,,"left",effect,,,,,,,,,,,,
	,"Browse ads","classifieds.htm",,,0
	,"Post an ad","post.htm",,,0
	,"Remove an ad","remove.htm",,,0
	])
 
	addmenu(menu=["legal",
	,,105,0,"",style1,,"left",effect,,,,,,,,,,,,
	,"About","about.htm",,,0
	,"Disclaimer","disclaimer.htm",,,0
	,"Privacy policy","privacy.htm",,,0
	])
	
	addmenu(menu=["congress",
	,,55,0,"",style1,,"center",effect,,,,,,,,,,,,
	//," 2010 ","events2010.htm",,,0
	//," 2011 ","events2011.htm",,,0
	," 2012 ","events2012.htm",,,0
	," 2013 ","events2013.htm",,,0
	," 2014 ","events2014.htm",,,0
	])
		
	addmenu(menu=["scales",
	,,250,0,"",style1,,"left",effect,,,,,,,,,,,,

	," *NEW* Remission Evaluation and Mood Inventory Tool (REMIT)","remit.htm",,,0	
	," Depression, Anxiety, Stress Scales(DASS21)","dass.htm",,,0
	," Iowa Fatigue Scale (IFS)","iowa.htm",,,0
	," Quick Inventory of Depressive Symptomatology (QIDS)","qids.htm",,,0
	," Epworth Sleepiness Scale","epworth.htm",,,0
	," Brief Psychiatric Rating Scale","brief.htm",,,0
	," Apathy Evaluation Scale (AES)","aes.htm",,,0
	," Subjective Happiness Scale (SHS)","shs.htm",,,0
	," Yale-Brown Obsessive Compulsive Scale(YBOCS)","ybocs.htm",,,0
	," A battery of psychological tests ","psy_tests.htm",,,0
	," Depression and Somatic Symptoms Scale (DSSS)","dsss.htm",,,0
	," WHO-5. WHO-Five item Well-being Index","who-5.htm",,,0
	," GAD-7. 7-item GAD assessment scale","gad7.htm",,,0
	," Major Depression Inventory (MDI","mdi.htm",,,0
	," Social Phobia Inventory Self Test(SPIN)","spin.htm",,,0
	," Social Adaptation Self-evaluation Scale (SASS)","sass.htm",,,0
	," Edinburgh Postnatal Depression Scale (EPDS)","epds.htm",,,0
	," Zung Self-Rating Depression Scale (SDS)","zung_sds.htm",,,0
	," Liebowitz Social Anxiety Self-Rating Scale ","liebowitz.htm",,,0
	," Goldberg's Depression & Mania Self-Rating Scales ","goldberg.htm",,,0
	," Arizona Sexual Experience Scale (ASEX) ","asex.htm",,,0
	," Scale of Suicidal Ideation (SSI) ","ssi.htm",,,0
 	," Geriatric Depression Scale (GDS) ","gds.htm",,,0
  	," Hamilton Anxiety Rating Scale (HAMA)","hama.htm",,,0
   	," Hamilton Depression Rating Scale (HAMD-17)","hdrs.htm",,,0
   	," Clinical Global Impression Scale (CGI)","cgi.htm",,,0
	," Montgomery Asberg Depression Rating Scale (MADRS)","madrs.htm",,,0
	])
				
	addmenu(menu=["diagnostic",
	,,250,0,"",style1,,"left",effect,,,,,,,,,,,,
	," *NEW* CHAT - Checklist for Autism in Toddlers","chat.htm",,,0	
	," Internet Addiction Test","iat.htm",,,0
	," Newcastle Diagnostic and ECT prognosis Scales","newcastle.htm",,,0
	," Adult ADHD Self-Report Scale (ASRS)","adult_adhd_scale.htm",,,0
	," Brief Psychiatric Rating Scale","brief.htm",,,0
	," Bipolar Spectrum Diagnostic Scale (BSDS)","bsds.htm",,,0
	," Primary Care PTSD Screen","ptsd.htm",,,0
	," ADHD Rating Scale","adhd.htm",,,0
	," Center for Epidemiologic Studies - Depression Scale for children (CES-DC)","CES-DC.htm",,,0
	," Hospital Anxiety & Depression Scales (HAD)","had.htm",,,0
	," Major Depression Inventory (MDI)","mdi.htm",,,0
 	," Mood Disorder Questionnaire (MDQ)","mdq.htm",,,0
  	," Center for Epidemiologic Studies - Depression Scale (CES-D)","CES-D.htm",,,0
  	," PHQ-9 ","phq-9.htm",,,0
  	," PRIME-MD ","prime-md.htm",,,0
  	," DSM-IV ","show-menu=dsm-iv",,,0
 	," ICD-10 ","show-menu=icd-10",,,0
	])
		
	addmenu(menu=["dsm-iv",
	,,160,0,"",style1,,"left",effect,,,,,,,,,,,,
	," Depression ","dsmiv_depression.htm",,,0
  	," Generalised Anxiety Disorder ","dsmiv_gad.htm",,,0
	])	
	
	addmenu(menu=["icd-10",
	,,160,0,"",style1,,"left",effect,,,,,,,,,,,,
	," Depression ","icd10_depression.htm",,,0
 	," Generalised Anxiety Disorder ","icd10_gad.htm",,,0
	])
	
	addmenu(menu=["jove",
	,,200,0,"",style1,,"left",effect,,,,,,,,,,,,
	,"Selected videos from Journal of Video Experiments (JoVE)","jove01.htm",,,0
  	])
	
	addmenu(menu=["ndt",
	,,300,0,"",style1,,"left",effect,,,,,,,,,,,,
	,"*SELECTED RECENT PAPERS* 2011 Volume 7","ndt24.htm",,,0
	,"Selected papers 2010 Volume 6","ndt24.htm",,,0
	,"Selected papers 2009 Volume 5","ndt23.htm",,,0
	," Volume 4 number 6","ndt20.htm",,,0
	," Volume 4 number 5","ndt19.htm",,,0
	," Volume 4 number 4","ndt18.htm",,,0
	," Volume 4 number 3","ndt17.htm",,,0
	," Volume 4 number 2","ndt16.htm",,,0
	," Volume 4 number 1","ndt15.htm",,,0
  	," Earlier issues","show-menu=ndt_earlier_vols",,,0
  	])
	
	addmenu(menu=["ndt_earlier_vols",
	,,200,0,"",style1,,"left",effect,,,,,,,,,,,,
	," Volume 3 number 6","ndt14.htm",,,0
	," Volume 3 number 5","ndt13.htm",,,0
	," Volume 3 number 4","ndt12.htm",,,0
  	," Volume 3 number 3","ndt11.htm",,,0
  	," Volume 3 number 2","ndt10.htm",,,0
  	," Volume 3 number 1","ndt9.htm",,,0
  	," Volume 2 number 4","ndt8.htm",,,0
 	," Volume 2 number 3","ndt7.htm",,,0
 	," Volume 2 number 2","ndt6.htm",,,0
  	," Volume 2 number 1","ndt5.htm",,,0
  	," Volume 1 number 4","ndt4.htm",,,0
  	," Volume 1 number 3","ndt3.htm",,,0
  	," Volume 1 number 2","ndt2.htm",,,0
  	," Volume 1 number 1","ndt.htm",,,0
  	])
	
	addmenu(menu=["ijpcp",
	,,200,0,"",style1,,"left",effect,,,,,,,,,,,,
	,"This journal is no longer<BR>featured by psy-world.com","",,,0
	])
	
	addmenu(menu=["cns_spectrums",
	,,160,0,"",style1,,"left",effect,,,,,,,,,,,,
	," CNS Spectrums is no longer <BR> featured by psy-world.com","",,,0
	," Volume 14 number 5","cns_spectrums14-05.htm",,,0
	," Volume 14 number 4","cns_spectrums14-04.htm",,,0
	," Volume 14 number 3","cns_spectrums14-03.htm",,,0
	," Volume 14 number 2","cns_spectrums14-02.htm",,,0
	," Volume 13 number 12","cns_spectrums13-12.htm",,,0
	," Volume 13 number 11","cns_spectrums13-11.htm",,,0
	," Volume 13 number 10","cns_spectrums13-10.htm",,,0
	," Volume 13 number 9","cns_spectrums13-9.htm",,,0
	,"*CLINICAL SUPPLEMENT* Everyday Problems in Treating Depression: Focus on Serotonin Norepinephrine Reuptake Inhibitors","http://www.cnsspectrums.com/aspx/clinicalsupplements.aspx",,,0
	," Volume 13 number 8","cns_spectrums13-8.htm",,,0
	," Volume 13 number 7","cns_spectrums13-7.htm",,,0
	," Volume 13 number 6","cns_spectrums13-6.htm",,,0
	," Volume 13 number 5","cns_spectrums13-5.htm",,,0
	," Volume 13 number 4","cns_spectrums13-4.htm",,,0
	," Volume 13 number 3","cns_spectrums13-3.htm",,,0
	," Volume 13 number 2","cns_spectrums13-2.htm",,,0
	," Volume 13 number 1","cns_spectrums13-1.htm",,,0
	," Volume 12 2007","show-menu=cns_spectrums2007",,,0
	])
	
	addmenu(menu=["cns_spectrums2007",
	,,200,0,"",style1,,"left",effect,,,,,,,,,,,,	
	," Volume 12 number 12","cns_spectrums12-12.htm",,,0
	," Volume 12 number 11","cns_spectrums12-11.htm",,,0
	," Volume 12 number 10","cns_spectrums12-10.htm",,,0
	," Volume 12 number 9","cns_spectrums12-9.htm",,,0
	," Volume 12 number 8","cns_spectrums12-8.htm",,,0
  	," Volume 12 number 7","cns_spectrums12-7.htm",,,0
	," Volume 12 number 6","cns_spectrums12-6.htm",,,0
	," Volume 12 number 5","cns_spectrums12-5.htm",,,0
	])
		
	addmenu(menu=["controversy",
	,,200,0,"",style1,,"left",effect,,,,,,,,,,,,
	,"1. SSRIs and suicidality","show-menu=ssri-suicide",,,0
	,"2. Cholesterol and suicidality","show-menu=cholesterol-suicide",,,0
	])
	
	addmenu(menu=["ssri-suicide",
	,,400,0,"",style1,,"left",effect,,,,,,,,,,,,
	,"15. Do SSRIs or antidepressants in general increase suicidality? The WPA Section on Pharmacopsychiatry consensus statement","controv01-15.htm",,,0
	,"14. Antidepressants and Youth Suicide in New York City,1999-2002","controv01-14.htm",,,0
	,"13. Antidepressants in adult suicides in New York City: 2001-2004","controv01-13.htm",,,0
	,"12. Relationship between antidepressants and suicide attempts: An analysis of the Veterans Health Administration data sets","controv01-12.htm",,,0
	,"11. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials","controv01-11.htm",,,0
	,"10. Is there evidence for negative effects of antidepressants on suicidality in depressive patients?","controv01-10.htm",,,0
	,"9. NIMH funds 5 new major research projects","controv01-09.htm",,,0
	,"8. Even more suicide attempts in placebo trials with paroxetine","controv01-08.htm",,,0
	,"7. Suicide attempts in placebo trials of paroxetine","controv01-07.htm",,,0
	,"6. Forensic database study of 14 857 suicides","controv01-06.htm",,,0
	,"5. Systematic review of randomised controlled trials","controv01-05.htm",,,0
	,"4. Antidepressant treatment and risk of fatal and non-fatal self harm","controv01-04.htm",,,0
	,"3. Meta-analysis of drug company data from placebo controlled randomised trials","controv01-03.htm",,,0
	,"2. Relationship between antidepressant medication use and rate of suicide ","controv01-02.htm",,,0
	,"1. Antidepressants and suicide risk in USA 1985-1999","controv01-01.htm",,,0
	])
		
	addmenu(menu=["cholesterol-suicide",
	,,400,0,"",style1,,"left",effect,,,,,,,,,,,,
	,"7. Low plasma cholesterol levels in suicidal males: a gender- and body mass index-matched case-control study of suicide attempters and non-attempters.","controv02-07.htm",,,0
	,"6. Cholesterol and suicide attempts: A prospective study of depressed inpatients.","controv02-06.htm",,,0
	,"5. Platelet serotonin and serum cholesterol concentrations in suicidal and non-suicidal male patients with a first episode of psychosis.","controv02-05.htm",,,0
	,"4. Cholesterol content in brains of suicide completers.","controv02-04.htm",,,0
	,"3. No relationship between serum cholesterol and suicidal ideation and depression in African-American diabetics.","controv02-03.htm",,,0
	,"2. High cholesterol, triglycerides, and body-mass index in suicide attempters. ","controv02-02.htm",,,0
	,"1. Low HDL cholesterol is associated with suicide attempts among young healthy women.","controv02-01.htm",,,0
	])		
	
	addmenu(menu=["stahl",
	,,250,0,"",style1,,"left",effect,,,,,,,,,,,,
	," Essential PsychopharmaStahlogy","show-menu=psycho","stahl.htm#psycho",,0
	," Second Messenger","show-menu=second","stahl.htm#second",,0
	])
	
	addmenu(menu=["stahl_articles",
	,,400,0,"",style1,,"left",effect,,,,,,,,,,,,
	,"21. The Mechanism of Drug-induced Akathisia (co-authored with Anton J.M. Loonen)","stahl_articles.htm#21","",,0
	,"20. Play it Again: The Master Psychopharmacology Program as an Example of Interval Learning in Bite-Sized Portions","stahl_articles.htm#20","",,0
	,"19. Fooling Mother Nature: Epigenetics and Novel Treatments for Psychiatric Disorders","stahl_articles.htm#19","",,0
	,"18. Enhancing Outcomes from Major Depression: Using Antidepressant Combination Therapies with Multifunctional Pharmacologic Mechanisms from the Initiation of Treatment","stahl_articles.htm#18","",,0
	,"17. Crisis in Army Psychopharmacology and Mental Health Care at Fort Hood","stahl_articles.htm#17","",,0
	,"16. Mechanism of Action of Trazodone: a Multifunctional Drug","stahl_articles.htm#16","",,0
	,"15. Applying the Principles of Adult Learning to the Teaching of Psychopharmacology: Audience Response Systems","stahl_articles.htm#15","",,0
	,"14. Applying the Principles of Adult Learning to the Teaching of Psychopharmacology:  Storyboarding a Presentation and the Rule of Small Multiples","stahl_articles.htm#14","",,0
	,"13. Applying the Principles of Adult Learning to the Teaching of Psychopharmacology:  Overview and Finding the Focus","stahl_articles.htm#13","",,0
	,"12. Multifunctional Drugs: A Novel Concept for Psychopharmacology","stahl_articles.htm#12","",,0
	,"11. Selective Histamine H1 Antagonism: Novel Hypnotic and Pharmacologic Actions Challenge Classical Notions of Antihistamines","stahl_articles.htm#11","",,0
	,"10. Monoamine Oxidase Inhibitors: A Modern Guide to an Unrequited Class of Antidepressants","stahl_articles.htm#10","",,0
	,"9. Tailoring Treatment of Depression for Women Across the Reproductive Lifecycle","stahl_articles.htm#9","",,0
	,"8. The Potential Role of a Corticotropin-Releasing Factor Receptor-1 Antagonist in Psychiatric Disorders","stahl_articles.htm#8","",,0
	,"7. Do Dopamine Partial Agonists Have Partial Efficacy as Antipsychotics?","stahl_articles.htm#7","",,0
	,"6. Personalized Medicine, Pharmacogenomics, and the Practice of Psychiatry: On the Threshold of Predictive Therapeutics in Psychopharmacology?","stahl_articles.htm#6","",,0
	,"5. Novel Therapeutics for Depression: L-methylfolate as a Trimonoamine Modulator and Antidepressant-Augmenting Agent","stahl_articles.htm#5","",,0
	,"4. The Genetics of Schizophrenia converge upon the NMDA glutamate receptor","stahl_articles.htm#4","",,0
	,"3. Novel Therapeutics for Schizophrenia: Targeting Glycine Modulation of NMDA Glutamate Receptors","stahl_articles.htm#3","",,0
	,"2. Beyond the dopamine hypothesis to the NMDA glutamate receptor hypofunction hypothesis of schizophrenia","stahl_articles.htm#2","",,0
	,"1. Overview of trends in modern psychopharmacology","stahl_articles.htm#1","",,0
	])
	
	addmenu(menu=["psycho",
	,,250,0,"",style1,,"left",effect,,,,,,,,,,,,
	,"Let Them Eat Generics - can one atypical antipsychotic substitute for another","stahl.htm#ep1",,,0
	,"Fixing Pharma and the Feds - What the pharmaceutical industry and the FDA can do to restore their reputations","stahl.htm#ep1",,,0
	,"Strategies for Innovating New Treatments in Psychiatry","stahl.htm#ep1",,,0
	,"Prescribing Off-Label in Psychopharmacology. Is it the exception or the rule?","stahl.htm#ep1",,,0
	,"Symptoms and Circuits - Deconstructing psychiatric disorders to achieve remission","stahl.htm#ep1",,,0
	,"Will CATIE Change Your Practice? - A recent head-to-head study of antipsychotics may raise more questions than it answers","stahl.htm#ep1",,,0
	,"Processes Influencing Wakefulness","stahl.htm#ep1",,,0
	])
	
	addmenu(menu=["second",
	,,250,0,"",style1,,"left",effect,,,,,,,,,,,,
	,"Thomas Edison's Legacy - dealing with sleep problems in shift workers","stahl.htm#sm1",,,0
	,"Relatively Speaking,How Odd Can Hazards be? Interpreting the odds ratio","stahl.htm#sm1",,,0
	,"The Prostate Apoptosis Response 4 (PAR-4)A new role for an old protein in depression","stahl.htm#sm1",,,0
	,"Worried Sick: Antidepressants as Anti-Inflammatory Agents.","stahl.htm#sm1",,,0
	,"The Mystery of Fibromyalgia - Is fibromyalgia real pain, and what causes it?","stahl.htm#sm1",,,0
	,"The Mystery of Fibromyalgia - What drugs are effective in treating fibromyalgia and how do they work?","stahl.htm#sm1",,,0
	,"Educational Outcomes - The goals of continuing medical education","stahl.htm#sm1",,,0
	])
	
	addmenu(menu=["understanding",
	,,240,0,"",style1,,"left",effect,,,,,,,,,,,,
	,"Understanding Neurotransmission<BR>in the brain<BR>by Chantal Moret","show-menu=unt",,"",0
	])
	
	addmenu(menu=["unt",
	,,140,0,"",style1,,"left",effect,,,,,,,,,,,,
	,"Introduction","unt_intro.htm",,"",0
	,"Neurotransmission","unt_neurotrans.htm",,"",0
	,"Neurotransmitters","show-menu=nts",,"",0
	,"Diseases","show-menu=diseases",,"",0
	,"Drugs","show-menu=drugs",,"",0
	])
	
	addmenu(menu=["nts",
	,,110,0,"",style1,,"left",effect,,,,,,,,,,,,
	," Serotonin ","unt_serotonin.htm",,,0
 	," Noradrenaline ","unt_noradr.htm",,,0
 	," Dopamine ","unt_dopamine.htm",,,0
 	," Acetylcholine ","unt_ach.htm",,,0
 	," Histamine ","unt_histamine.htm",,,0
 	," GABA ","unt_gaba.htm",,,0
 	," Glutamate ","unt_glu.htm",,,0
	])
	
	addmenu(menu=["diseases",
	,,90,0,"",style1,,"left",effect,,,,,,,,,,,,
	," Depression ","show-menu=depression",,,0
	])
	
	addmenu(menu=["drugs",
	,,120,0,"",style1,,"left",effect,,,,,,,,,,,,
	,"Antidepressants ","show-menu=antidep2",,,0
 	])
 	
 	addmenu(menu=["depression",
	,,135,0,"",style1,,"left",effect,,,,,,,,,,,,
	,"Evidence-based involvement of monoamines","unt_depression2.htm",,,0
	,"Neurotransmitters, pathways and symptoms","unt_pathsymp.htm",,,0
	,"Neurogenesis hypothesis of depression","unt_neurogen1.htm",,,0
  	])
 
	addmenu(menu=["antidep2",
	,,120,0,"",style1,,"left",effect,,,,,,,,,,,,
	,"Monotherapy","unt_antidepressants.htm",,,0
	,"Combinations & augmentation strategies","unt_antidepressants.htm#comb",,,0
  	])

	dumpmenus()